p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate
- 15 February 2006
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 93 (3) , 241-252
Abstract
Background and Objectives As a significant number of curatively treated gastric cancer patients will ultimately relapse, there is an urgent need to investigate new prognostic markers for identification of high‐risk patients. In this study, we investigated the possible role of molecular markers involved in cell cycle regulation (B1 and D3 cyclins, and p27) and cell protection (metallothionein, MT) in predicting tumor behavior and clinical outcome in gastric cancer patients. Methods Analysis of the above indicators was performed by immunohistochemistry on 73 gastric cancer patient samples and 25 normal gastric mucosa specimens. Results Normal gastric mucosa cells displayed low expressions of B1 and D3 cyclins and MT, and intense p27 staining. Conversely, gastric tumor cells showed higher cyclin D3 and MT, and lower p27 expressions. B1 cyclin expressions were not different between normal and tumor tissue. p27 and MT expressions were altered in almost all cancer samples, and were strongly correlated with tumor progression. Advanced extent of the primary tumor, nodal metastasis, low p27, and high MT expressions were the best combination of variables for prediction of poor clinical outcome. Each marker predicted outcome better than staging based on tumor‐node (TNM) system. Survival and recurrence rates decreased as molecular alterations increased. Finally, molecular profile determination correctly predicted the prognosis in patients with same TNM stage. Conclusions p27 and MT expressions strongly correlated with clinical outcome allowing to identify an unfavorable group of patients that may benefit from tailored treatments. The role of B1 and D3 cyclins in gastric cancer remains to be elucidated. J. Surg. Oncol. 2006;93: 241–252.Keywords
This publication has 35 references indexed in Scilit:
- Chromosomal and microsatellite instability in sporadic gastric cancerJournal of Gastroenterology and Hepatology, 2004
- Recent Results in Understanding Molecular Pathways in the Medical Treatment of Esophageal and Gastric CancerOncology Research and Treatment, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Prognostic significance of metastatic lymph node size in patients with gastric cancerBritish Journal of Surgery, 2003
- Mutations in the yeast cyclin-dependent kinase Cdc28 reveal a role in the spindle assembly checkpointMolecular Genetics and Genomics, 2003
- Randomized Trial of Adjuvant Chemotherapy With Mitomycin, Fluorouracil, and Cytosine Arabinoside Followed by Oral Fluorouracil in Serosa-Negative Gastric Cancer: Japan Clinical Oncology Group 9206–1Journal of Clinical Oncology, 2003
- Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcomeJournal of Surgical Oncology, 2002
- Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancerBritish Journal of Surgery, 2002
- Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological studyJournal of Cancer Research and Clinical Oncology, 2002
- Cancer Cell CyclesScience, 1996